Competitive Advantages

Somahlutions flagship product, DuraGraft, is first in class. DuraGraft has been designed for strong, superior performance as compared to other standard of care products. The superior design has long lasting health benefits to patients, and supportive health economic benefits to hospitals

Market Expansion

Somahlution is expanding its markets through strategic collaborations with key partners

A Leading

Innovator in the Global Biotechnology Market

Somahlution is dedicated to developing, manufacturing, and marketing products of the highest quality to serve the needs of our customers worldwide. Our scientific and medical expertise, with a unique patient-inspired focus, forms the foundation of our commitment to science with a purpose.

OUR PRODUCTS

DuraGraft is a vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure. DuraGraft enhances CABG outcomes by significantly reducing major cardiac events such as repeat revascularization, myocardial infarction and MACE.

0

0

Reduction in Myocardial Infarction Rates

0

0

Reduction in Repeat Revascularization Rates

0

0

Reduction in MACE Rates

Medical & Hospital Professionals

At Somahlution, we work with medical professionals and hospitals to provide new medical technologies that not only benefit patients globally, but also help hospitals improve their quality performance ratings.